Newsroom Search

featured news

November 28, 2014 General

Netherlands-Based Organon, Inc. Settles Healthcare Fraud Claims for $34 Million

The False Claims Act is not limited only to domestic instances of fraud against the government. To the contrary, companies headquartered in other countries are routinely targeted for fraud investigations, including a recent False Claims Act case against a Netherlands-based drug company now owned by the more familiar corporation Merck. […]
November 27, 2014 General

Medical Device Manufacturer Biotronik Settles False Claims Act Allegations for $4.9 Million

Biotronik, Inc., a medical device manufacturer, has agreed to pay $4.9 million to settle claims it unlawfully engaged in kickback schemes and prohibited financial arrangements in violation of the False Claims Act and its terms forbidding kickback schemes pertaining to Medicare and Medicaid patients. The company settled with the Department […]
November 26, 2014 General

Bone Growth Stimulator Manufacturer Biomet Inc. Settles Allegations It Defrauded the Government

New Jersey-based Biomet, Inc. has agreed to pay $6.07 million to settle False Claims Act allegations involving kickbacks pertaining to its bone growth stimulator products. Under the False Claims Act, any medical device manufacturer, drug company, hospital, or medical professional may face possible liability if Medicare or Medicaid patients are […]
November 25, 2014 General

Houston-Based One Step Diagnostic Agrees to Settle False Claims Act Case for $2.6 Million

Houston-based One Step Diagnostic, which operates several medical imaging diagnostic centers around Houston, Texas, has agreed to pay $2.6 million to the federal government in order to settle claims it engaged in unlawful kickbacks and inappropriate financial relationships in violation of the False Claims Act and federal Stark Law. The […]
November 20, 2014 General

CA District Court Reiterates Need for Strong Evidence in Whistleblower Lawsuits in Serco Judgment

We have covered the False Claims Act evidentiary standard from a number of different angles. At the pleadings phase of these cases, there is a near 50/50 split between the circuit courts as to the specificity of alleged fraud necessary to overcome a motion to dismiss under Federal Rule of […]